| Literature DB >> 32671104 |
Jasmin Nessler1, Peter Wohlsein2, Johannes Junginger2, Florian Hansmann2, Johannes Erath1, Franz Söbbeler1, Peter Dziallas1, Andrea Tipold1.
Abstract
Meningoencephalomyelitis of unknown origin (MUO) is an umbrella term describing inflammatory changes of the central nervous system (CNS) with suspected non-infectious etiology. Diagnosis of MUO mostly remains presumed in a clinical setting. Histopathological and immunohistochemical examination of CNS tissue represent additional tools for detection of inflammation and the exclusion of specific infectious agents. While MUO is well-described in canine patients, only little is known about MUO in cats. Previous reports of feline MUO involve either clinical findings or histopathological examination but not both. The present case series is the first report describing both clinical and histopathological findings of feline MUO: Four cats (age: 1.7-17.8 years) showed acute to chronic progressive neurological signs of encephalopathy or myelopathy. Three cats had extraneural signs (hyperthermia, weight loss, hyporexia, leukocytosis). Magnetic resonance imaging (MRI) showed multifocal intraparenchymal lesions in forebrain, brainstem or spinal cord with homogenous contrast enhancement (2/2). Cerebrospinal fluid (CSF) examination was normal or displayed albuminocytologic dissociation. Histopathology revealed a multifocal, lympho-histiocytic meningoencephalitis in three cases and a lympho-histiocytic myelitis in one case. Immunohistochemistry for feline parvovirus, feline coronavirus, feline herpesvirus, tick borne encephalitis virus, Borna disease virus, morbillivirus, rabies virus, suid herpesvirus-1, and Toxoplasma gondii were negative in all cases. ONE SENTENCEEntities:
Keywords: MRI; MUO; encephalitis; feline; lympho-histiocytic; necropsy; non-infectious
Year: 2020 PMID: 32671104 PMCID: PMC7326087 DOI: 10.3389/fvets.2020.00291
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Cats with presumed and confirmed diagnosis of encephalitis (2012–2019): comparison between cats with necropsy confirmed MUO, clinically suspected MUO, other encephalitides and clinic population.
| MUO, confirmed with necropsy (cases 1–4) | mn; | DSH; | 7 (1–17) | Leukocytes: 14.75 | TP: 45.67 mg/dl (17–72); | AED | |||
| Hyperglycemia | Cells: 3 cells/3 μl (0–5); | ||||||||
| MUO, clinically suspected | m; | DSH; | 7.04 (0.3–15) | Leukocytes: 8.9 (6.1–12.6); | TP: 57.57 mg/dl (6–187); | AED | |||
| Limbic encephalitis | m; | DSH; | 4.17 (2) | Leukocytes: 11.76 | TP: 18.6 mg/dl (14–24); | AED | |||
| Cells: 3.83 cells/3 μl (1–9); | |||||||||
| FIP | m; | DSH; | 2.5 (0.5–11) | Leukocytes: 14.85 | TP: 1,129 mg/dl (745–2,200; | Euthanasia | |||
| Cells: 677.67 cells/3 μl (260–2,160); | |||||||||
| Encephalitis secondary to otitis interna | m; | DSH; | 4.88 (0.3–12) | Leukocytes: 12.5 | TP: 374 mg/dl (0-1714); | AB | |||
| Cells: 1,593 cells/3 μl (0–7,936); | |||||||||
| Other bacterial encephalitis | m; | DSH; | 5 (2–8) | Leukocytes:13.45 | TP: 20.9 mg/dl | AB | |||
| Cells: 1,197 cells/3 μl (94–2,300); | |||||||||
| Toxoplasmosis | f; | DSH; | 1 | Leukocytes: 25.1 | TP: 17 mg/dl; | np | AB; follow up 6 months | ||
| Cells: 20 cells/3 μl; | |||||||||
| Presumed inflammatory brain lesion | fn; | DSH; | 6 (4–8) | Abnormal | Leukocytes: 13.15 | TP: 49.5 mg/dl (31-68); n=2/2 | Dead after 1 week | ||
| Cells: 44.5 cells/3 μl (5–84); | |||||||||
| All cats in the clinic 2012–2019 | m 9.2% | DSH 69.8% |
MUO, meningoencephalomyelitis of unknown origin; FIP, feline infectious peritonitis; m, male; mn, male neutered; f, female; fn, female neutered; min, minimum; max, maximum; DSH, Domestic Shorthair Cat; DLH, Domestic Longhair Cat; MC, Maine Coon Cat; NF, Norwegian Forrest Cat; BSH, British Shorthair Cat; body temp, rectal body temperature; CSF, cerebrospinal fluid; TP, total proteine; neutrophilic, neutrophilic pleocytosis, lymphocytic, lymphocytic pleocytosis; mixed, mixed cell pleocytosis; pandy pos, positive Pandy's reaction.
CSF and MRI suspicious of inflammatory CNS disease, but owner refused further investigation; leukocytes, reference range 6–11.
Magnetic resonance imaging (MRI) sequences and planes used for each cat.
| Scanned region | Brain | Brain | Spinal cord, brain |
| T2w | trans, sag, dor | trans, sag, dor | trans (T7-L1), sag (olfactory bulb to Cd5) |
| T1w | n.d. | trans, sag, dor | n.d. |
| T1w | n.d. | trans, sag, dor | trans (T11-13), sag (C5-L7) |
| GRASE | trans | trans | trans (T9-L1) |
| FLAIR | n.d. | trans | n.d. |
| DWI/ADC | n.d. | trans | n.d. |
| Fast spin echo | n.d. | n.d. | trans (T9-L1) |
T2w, T2 weighted; T1w, T1 weighted; DWI/ADC, diffusion weighted imaging/apparent diffusion coefficient; GRASE, Gradient and Spin Echo; FLAIR, Fluid-attenuated inversion recovery (=Long Tau Inversion Recovery); trans, transversal plane; sag, sagital plane; dor, dorsal plane; T, thoracic spinal segment; L, lumbar spinal segment; C, cervical spinal segment; Cd, caudal spinal segment.
Scans were performed post-mortem; n.d., not performed.
Contrast medium (gadoteric acid 1 mmol/kg, megluminum 195 mg/kg, Dotarem®, Guerbet AG, Zürich, Swiss).
Figure 1Cat no. 1. (A,B) Histopathology. (A) Cerebral cortex, the leptomeninx (arrows) and neuroparenchyma (black arrowheads) is severely infiltrated with mononuclear inflammatory cells associated with rod-shaped microglial cells (white arrows) in the adjacent neuroparenchyma. HE, bar = 50 μm. (B) Cerebral cortex showing severe vasculitis with mural and perivascular infiltration of lymphocytes (arrows), macrophages (white arrowheads), and plasma cells (black arrowheads). HE, bar = 60 μm.
Figure 2Cat no. 2. (A,B) Magnetic resonance imaging (MRI): Midsagittal (A) and transversal section (B) of the brain of cat 2 at the level of the interthalamic adhesion in T2 weighted (T2w) sequences. Note the intramedullary hyperintense lesions of the brainstem and the subcortical white matter as well as the mass lesion with signal void in the myelencephalon. Left side is marked with L. (C–E) Histopathology. (C) Pons, focally severe meningitis (X) with severe hemorrhages in the adjacent neuroparenchyma (arrow) and vacuolization of the white matter as well as spheroids (arrowheads), HE, bar = 100 μm. (D) Hippocampus, severe neuronal necrosis (arrows) and loss. HE, bar = 50 μm. (E) Cerebral cortex with focally severe, perivascular, lympho-histiocytic encephalitis. HE, bar = 60 μm.
Figure 3Cat no. 3. (A,B) Magnetic resonance imaging (MRI): Dorsal (A) and transversal section (B) of the brain at the level of the interthalamic adhesion in T1w sequences post-contrast application. Note the small rim of contrast enhancement in the lateral ependymal lining of the right lateral ventricle and the slightly decreased volume of the right lateral ventricle. Left side is marked with L. (C–F) Histopathology. (C) Hippocampus with severe neuronal loss in the CA2 and CA3 regions (arrowheads). HE, bar = 100 μm. (D) Periventricular white matter with severe microgliosis (black arrowheads), infiltration of gitter cells (blue arrowheads) and gemistocytes (arrows). HE, bar = 50 μm. (E) Brain stem, moderate lympho-histiocytic perivascular encephalitis with prominent microgliosis (arrowheads), astrocytosis and presence of gemistocytes (arrows). HE, bar = 60 μm.
Figure 4Cat no. 4. (A,B) Magnetic resonance imaging (MRI): Midsagittal section of the spinal cord at the thoracolumbar junction in T2w (A) and T1w post-contrast (B) sequences. First lumbar vertebra is marked with L1. Note the intramedullary hyperintense signal (A) from T11 to L1 and the focal contrast enhancement at the level of T12 (B). (C) Histopathology: Thoracic spinal cord showing a focally extensive severe lympho-histiocytic inflammation (X) associated with dilatation of myelin sheaths and swollen axons (arrowheads). In addition, a severe meningeal fibrosis is present (arrows). HE, bar = 100 μm.